Articles - 3um5 mentioned but not cited (1)
- Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil. Vanichtanankul J, Taweechai S, Uttamapinant C, Chitnumsub P, Vilaivan T, Yuthavong Y, Kamchonwongpaisan S. Antimicrob Agents Chemother 56 3928-3935 (2012)
Reviews citing this publication (3)
- Folate metabolism in human malaria parasites--75 years on. Müller IB, Hyde JE. Mol Biochem Parasitol 188 63-77 (2013)
- The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations. Ogungbe IV, Setzer WN. Molecules 21 E1389 (2016)
- An epigrammatic status of the 'azole'-based antimalarial drugs. Sharma M, Prasher P. RSC Med Chem 11 184-211 (2020)
Articles citing this publication (11)
- Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Bridges HR, Jones AJ, Pollak MN, Hirst J. Biochem J 462 475-487 (2014)
- Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis. Abbat S, Jain V, Bharatam PV. J Biomol Struct Dyn 33 1913-1928 (2015)
- Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR. David TI, Adelakun NS, Omotuyi OI, Metibemu DS, Ekun OE, Eniafe GO, Inyang OK, Adewumi B, Enejoh OA, Owolabi RT, Oribamise EI. Bioinformation 14 574-579 (2018)
- Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia. Basuki S, Fitriah, Riyanto S, Budiono, Dachlan YP, Uemura H. Malar J 13 135 (2014)
- In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria. Wadood A, Ghufran M, Hassan SF, Khan H, Azam SS, Rashid U. Pharm Biol 55 19-32 (2017)
- Targeting plant DIHYDROFOLATE REDUCTASE with antifolates and mechanisms for genetic resistance. Corral MG, Haywood J, Stehl LH, Stubbs KA, Murcha MW, Mylne JS. Plant J (2018)
- Design, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolates. Lourens AC, Gravestock D, van Zyl RL, Hoppe HC, Kolesnikova N, Taweechai S, Yuthavong Y, Kamchonwongpaisan S, Rousseau AL. Org Biomol Chem 14 7899-7911 (2016)
- Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening. Hoarau M, Vanichtanankul J, Srimongkolpithak N, Vitsupakorn D, Yuthavong Y, Kamchonwongpaisan S. J Enzyme Inhib Med Chem 36 198-206 (2021)
- Molecular Docking Studies, Synthesis and Biological Evaluation of Substituted Pyrimidine-2,4-diamines as Inhibitors of Plasmodium falciparum Dihydrofolate Reductase. Somandi K, Seanego TD, Dlamini Née Molatsane T, Maree M, de Koning CB, Vanichtanankul J, Rattanajak R, Saeyang T, Yuthavong Y, Kamchonwongpaisan S, Rousseau AL. ChemMedChem 17 e202200418 (2022)
- Application of molecular docking and PSO-SVR intelligent approaches in antimalarial activity prediction of enantiomeric cycloguanil analogues. Inthajak K, Toochinda P, Lawtrakul L. SAR QSAR Environ Res 29 957-974 (2018)
- Theoretical Investigation of the Enantioselective Complexations between pfDHFR and Cycloguanil Derivatives. Kulatee S, Toochinda P, Suksangpanomrung A, Lawtrakul L. Sci Pharm 85 E37 (2017)